266 related articles for article (PubMed ID: 28330377)
1. Enhanced oral bioavailability and sustained delivery of glimepiride via niosomal encapsulation: in-vitro characterization and in-vivo evaluation.
Mohsen AM; AbouSamra MM; ElShebiney SA
Drug Dev Ind Pharm; 2017 Aug; 43(8):1254-1264. PubMed ID: 28330377
[TBL] [Abstract][Full Text] [Related]
2. Development and biological evaluation of Gymnema sylvestre extract-loaded nonionic surfactant-based niosomes.
Kamble B; Talreja S; Gupta A; Patil D; Pathak D; Moothedath I; Duraiswamy B
Nanomedicine (Lond); 2013 Aug; 8(8):1295-305. PubMed ID: 23259778
[TBL] [Abstract][Full Text] [Related]
3. Niosomes for oral delivery of nateglinide: in situ-in vivo correlation.
Sultan AA; El-Gizawy SA; Osman MA; El Maghraby GM
J Liposome Res; 2018 Sep; 28(3):209-217. PubMed ID: 28618876
[TBL] [Abstract][Full Text] [Related]
4. Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge.
Arzani G; Haeri A; Daeihamed M; Bakhtiari-Kaboutaraki H; Dadashzadeh S
Int J Nanomedicine; 2015; 10():4797-813. PubMed ID: 26251598
[TBL] [Abstract][Full Text] [Related]
5. Niosomes with sorbitan monoester as a carrier for vaginal delivery of insulin: studies in rats.
Ning M; Guo Y; Pan H; Yu H; Gu Z
Drug Deliv; 2005; 12(6):399-407. PubMed ID: 16253956
[TBL] [Abstract][Full Text] [Related]
6. Enhanced oral bioavailability of griseofulvin via niosomes.
Jadon PS; Gajbhiye V; Jadon RS; Gajbhiye KR; Ganesh N
AAPS PharmSciTech; 2009; 10(4):1186-92. PubMed ID: 19856107
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
[TBL] [Abstract][Full Text] [Related]
8. Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies.
El-Nabarawi MA; Abd El Rehem RT; Teaima M; Abary M; El-Mofty HM; Khafagy MM; Lotfy NM; Salah M
Drug Dev Ind Pharm; 2019 Jun; 45(6):922-936. PubMed ID: 30744431
[TBL] [Abstract][Full Text] [Related]
9. Development and Characterization of a Glimepiride-Loaded Gelatin-Coated Mesoporous Hollow Silica Nanoparticle Formulation and Evaluation of Its Hypoglycemic Effect on Type-2 Diabetes Model Rats.
Yu X; Liu T; Lin R
Assay Drug Dev Technol; 2020; 18(8):369-378. PubMed ID: 33136434
[No Abstract] [Full Text] [Related]
10. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
11. Delivery of vinblastine-containing niosomes results in potent in vitro/in vivo cytotoxicity on tumor cells.
Amiri B; Ahmadvand H; Farhadi A; Najmafshar A; Chiani M; Norouzian D
Drug Dev Ind Pharm; 2018 Aug; 44(8):1371-1376. PubMed ID: 29532687
[TBL] [Abstract][Full Text] [Related]
12. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery.
Bayindir ZS; Yuksel N
J Pharm Sci; 2010 Apr; 99(4):2049-60. PubMed ID: 19780133
[TBL] [Abstract][Full Text] [Related]
13. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits.
Attia IA; El-Gizawy SA; Fouda MA; Donia AM
AAPS PharmSciTech; 2007 Dec; 8(4):E106. PubMed ID: 18181527
[TBL] [Abstract][Full Text] [Related]
14. Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement.
Kamboj S; Saini V; Bala S
ScientificWorldJournal; 2014; 2014():959741. PubMed ID: 24672401
[TBL] [Abstract][Full Text] [Related]
15. Synthesized nano particles of glimepiride via spray freezing into cryogenic liquid: characterization, antidiabetic activity, and bioavailability.
Gaber DA; Alhuwaymili AS; Alhawas HS; Almutiri AA; Alsubaiyel AM; Abdoun SA; Almutairi RA
Drug Deliv; 2022 Dec; 29(1):364-373. PubMed ID: 35068278
[TBL] [Abstract][Full Text] [Related]
16. Intranasal niosomes of nefopam with improved bioavailability: preparation, optimization, and in-vivo evaluation.
Abou-Taleb HA; Khallaf RA; Abdel-Aleem JA
Drug Des Devel Ther; 2018; 12():3501-3516. PubMed ID: 30410310
[TBL] [Abstract][Full Text] [Related]
17. Sugar-based novel niosomal nanocarrier system for enhanced oral bioavailability of levofloxacin.
Imran M; Shah MR; Ullah F; Ullah S; Elhissi AM; Nawaz W; Ahmad F; Sadiq A; Ali I
Drug Deliv; 2016 Nov; 23(9):3653-3664. PubMed ID: 27886514
[TBL] [Abstract][Full Text] [Related]
18. Development of a biocompatible creatinine-based niosomal delivery system for enhanced oral bioavailability of clarithromycin.
Ullah S; Shah MR; Shoaib M; Imran M; Elhissi AM; Ahmad F; Ali I; Shah SW
Drug Deliv; 2016 Nov; 23(9):3480-3491. PubMed ID: 27247018
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic study of niosome encapsulated insulin.
Khaksa G; D'Souza R; Lewis S; Udupa N
Indian J Exp Biol; 2000 Sep; 38(9):901-5. PubMed ID: 12561948
[TBL] [Abstract][Full Text] [Related]
20. Metformin hydrochloride and wound healing: from nanoformulation to pharmacological evaluation.
El-Ridy MS; Yehia SA; Elsayed I; Younis MM; Abdel-Rahman RF; El-Gamil MA
J Liposome Res; 2019 Dec; 29(4):343-356. PubMed ID: 30526146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
